Neural Regeneration Research ›› 2016, Vol. 11 ›› Issue (3): 476-479.doi: 10.4103/1673-5374.179066

Previous Articles     Next Articles

Imipramine protects retinal ganglion cells from oxidative stress through the tyrosine kinase receptor B signaling pathway

Ming-lei Han, Guo-hua Liu, Jin Guo, Shu-juan Yu, Jing Huang   

  1. Department of Ophthalmology, Qilu Children Hospital, Shandong University, Jinan, Shandong Province, China
  • Received:2016-01-18 Online:2016-03-15 Published:2016-03-15
  • Contact: Ming-lei Han, M.D.,Dick_han@aol.com.

Abstract:

Retinal ganglion cell (RGC) degeneration is irreversible in glaucoma and tyrosine kinase receptor B (TrkB)-associated signaling pathways have been implicated in the process. In this study, we attempted to examine whether imipramine, a tricyclic antidepressant, may protect hydrogen peroxide (H2O2)-induced RGC degeneration through the activation of the TrkB pathway in RGC-5 cell lines. RGC-5 cell lines were pre-treated with imipramine 30 minutes before exposure to H2O2. Western blot assay showed that in H2O2-damaged RGC-5 cells, imipramine activated TrkB pathways through extracellular signal-regulated protein kinase/TrkB phosphorylation. TUNEL staining assay also demonstrated that imipramine ameliorated H2O2-induced apoptosis in RGC-5 cells. Finally, TrkB-IgG intervention was able to reverse the protective effect of imipramine on H2O2-induced RGC-5 apoptosis. Imipramine therefore protects RGCs from oxidative stress-induced apoptosis through the TrkB signaling pathway.

Key words: nerve regeneration, retinal ganglion cell, imipramine, oxidative stress, apoptosis, tyrosine kinase receptor B, neural regeneration